ReviewHeliyon2022
Functional silver nanoparticles synthesis from sustainable point of view: 2000 to 2023 ‒ A review on game changing materials.
Review in Heliyon, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed.
- Eco-friendly synthesis of silver nanoparticles as an unexplored application of photoredox catalysis.Nanoscale advances · 2026Article
- Ecofriendly synthesis of silver nanoparticles using Barleria gibsonii and evaluation of antibacterial antioxidant cytotoxic and catalytic activities.Scientific reports · 2026Article
- Green Synthesis of Ag/AgCl Nanoparticles From Argan Oil Waste: Characterization, Antibacterial, and Cytotoxicity Activities.Food science & nutrition · 2025Article
- Comprehensive Review of Silver Nanoparticles in Food Packaging Applications.International journal of molecular sciences · 2025Review
- Sustainable Synthesis of Silver Nanoparticles (Chemical vs Biological) and Their Antimicrobial Activity against Clinical Pathogens.ACS omega · 2025Article
- Electrically conductive biopolymer-based hydrogels and fibrous materials fabricated using 3D printing and electrospinning for cardiac tissue engineering.Bioactive materials · 2025Review
- Ecotoxicity of fungal-synthesized silver nanoparticles: mechanisms, impacts, and sustainable mitigation strategies.3 Biotech · 2025Review
- Phytofabricated silver nanoparticles unlock new potential in tomato plants by combating wilt infection and enhancing plant growth.Scientific reports · 2025Article
- Application of Fourier Transform Infrared (FTIR) Spectroscopy in Characterization of Green Synthesized Nanoparticles.Molecules (Basel, Switzerland) · 2025Review
- Green Advances in Wet Finishing Methods and Nanoparticles for Daily Textiles.Macromolecular rapid communications · 2025Review
- Design rules applied to silver nanoparticles synthesis: A practical example of machine learning application.Computational and structural biotechnology journal · 2024Article
- Pioneering Topical Ointment Intervention for Unprecedented Antimicrobial and Diabetic Wound Management with Phenylpropanoids and Nano-Silver.The AAPS journal · 2024Article
- Harnessing barley grains for green synthesis of gold and silver nanoparticles with antibacterial potential.Discover nano · 2024Article
- Review
- Synergistic Antibacterial Properties of Silver Nanoparticles and Its Reducing Agent from Cinnamon Bark Extract.Bioengineering (Basel, Switzerland) · 2024Article
- Advancing biomedical applications: an in-depth analysis of silver nanoparticles in antimicrobial, anticancer, and wound healing roles.Frontiers in pharmacology · 2024Review
- Green Synthesis of Metal and Metal Oxide Nanoparticles: A Review of the Principles and Biomedical Applications.International journal of molecular sciences · 2023Review
- Biosynthesized Silver Nanoparticles UsingACS omega · 2023Article
- Marine Biomaterials: Hyaluronan.Marine drugs · 2023Review
- Antiviral Activity of Biosynthesized Silver Nanoparticles from Pomegranate (Plants (Basel, Switzerland) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The green and facile synthesis of metallic silver nanoparticles (AgNPs) is getting tremendous attention for exploring superior applications because of their small dimensions and shape. AgNPs are already proven materials for superior coloration, biocidal, thermal, UV-protection, and mechanical performance. Originally, some conventional chemical-based reducing agents were used to synthesize AgNPs, but these posed potential risks, especially for enhanced toxicity. This became a driving force to innovate plant-based sustainable and green metallic nanoparticles (NPs). Moreover, the synthesized NPs using plant-based derivatives could be tuned and regulated to achieve the required shape and size of the AgNPs. AgNPs synthesized from naturally derived materials are safe, economical, eco-friendly, facile, and convenient, which is also motivating researchers to find greener routes and viable options, utilizing various parts of plants like flowers, stems, heartwood, leaves and carbohydrates like chitosan to meet the demands. This article intends to provide a comprehensive review of all aspects of AgNP materials, including green synthesis methodology and mechanism, incorporation of advanced technologies, morphological and elemental study, functional properties (coloration, UV-protection, biocidal, thermal, and mechanical properties), marketing value, future prospects and application, especially for the last 20 years or more. The article also includes a SWOT (Strengths, weaknesses, opportunities, and threats) analysis regarding the use of AgNPs. This report would facilitate the industries and consumers associated with AgNP synthesis and application through fulfilling the demand for sustainable, feasible, and low-cost product manufacturing protocols and their future prospects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.